C78.7
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Metachronous colorectal liver metastases. Fong score >= 4 Written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: - Type 1 diabetes mellitus - Chronic renal failure (GFR <= 60 ml/min) - Any factor that may limit the patient's ability to cooperate during the study (e.g., mental function or substance abuse) - Significant cognitive impairment, clinically relevant or progressive disease (e.g., liver, kidney, cardiovascular, respiratory, vascular, brain, metabolic, thyroid) that could affect the course of the study. - Concurrent participation in another AMG/MPG study - Existing dependence on alcohol, medication, drugs or nicotine abuse during the fasting period - Insufficient mental capacity to cooperate - Eating disorders - Kidney stones - Fatty acid oxidation disorders - Ketolysis/ketoneogenesis defects - Gluconeogenesis defects - Hyperinsulinism (e.g. nesidioblastoma) - Pyruvate carboxylase deficiency - Known bleeding tendency or use of anticoagulant medication (PTT, INR and platelets will be checked prior to study entry) - Pregnancy and lactation - Suspected noncompliance - Special diet for medical reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of the influence of a diet with a low glycemic load on the oncological course after surgical resection of colorectal liver metastases. For this over a period of 12 months, clinical imaging data are recorded at a total of 4 visits. | — |
Secondary
| Measure | Time frame |
|---|---|
| Determination of the patient compliance with the change in diet. | — |
Countries
Germany
Contacts
Uniklinik RWTH Aachen Allg.-, Viszeral-, Kinder & Transplantationschirurgie